Galmed Pharmaceuticals Gross Profit 2013-2025 | GLMD

Galmed Pharmaceuticals gross profit from 2013 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Galmed Pharmaceuticals Annual Gross Profit
(Millions of US $)
2024
2023
2022
2021
2020
2019
2018 $2
2017 $1
2016 $0
2015
2014
2013
2012
Galmed Pharmaceuticals Quarterly Gross Profit
(Millions of US $)
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $0
2018-09-30 $2
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-03-31
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.002B $0.000B
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $78.129B 29.67
Zoetis (ZTS) US $52.791B 18.89
Takeda Pharmaceutical (TAK) JP $43.625B 8.90
Daiichi Sankyo, - (DSNKY) JP $40.634B 20.24
BeOne Medicines - (ONC) CH $36.101B 191.40
Sandoz Group AG (SDZNY) CH $29.630B 0.00
United Therapeutics (UTHR) US $19.545B 17.20
Merck (MKKGY) DE $16.472B 10.71
Neurocrine Biosciences (NBIX) US $14.958B 35.89
Shionogi (SGIOY) JP $14.547B 13.36
Summit Therapeutics (SMMT) US $14.112B 0.00
IPSEN (IPSEY) FR $12.438B 0.00
Ionis Pharmaceuticals (IONS) US $11.264B 0.00
Madrigal Pharmaceuticals (MDGL) US $11.262B 0.00
Orion OYJ (ORINY) FI $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) US $7.941B 85.78
Stevanato Group S.p.A (STVN) IT $7.344B 41.10
Grifols, S.A (GRFS) ES $5.913B 0.00
Ono Pharmaceutical (OPHLF) JP $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) GB $4.546B 0.00
NewAmsterdam Pharma (NAMS) NL $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $3.606B 17.13
Centessa Pharmaceuticals (CNTA) GB $2.990B 0.00
Hypermarcas (HYPMY) BR $2.983B 22.43
Procaps Group, S.A (PROCF) LU $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.650B 8.45
Dyne Therapeutics (DYN) US $2.644B 0.00
Soleno Therapeutics (SLNO) US $2.487B 0.00
Ocular Therapeutix (OCUL) US $2.307B 0.00
Guardian Pharmacy Services (GRDN) US $1.884B 36.28
Collegium Pharmaceutical (COLL) US $1.376B 6.81
Amylyx Pharmaceuticals (AMLX) US $1.338B 0.00
Xeris Biopharma Holdings (XERS) US $1.281B 0.00
Harrow (HROW) US $1.263B 77.59
Nektar Therapeutics (NKTR) US $1.179B 0.00
Oruka Therapeutics (ORKA) US $1.161B 0.00
Enliven Therapeutics (ELVN) US $1.108B 0.00
Relay Therapeutics (RLAY) US $1.069B 0.00
Evotec AG (EVO) DE $1.062B 0.00
Xencor (XNCR) US $0.981B 0.00
Cronos Group (CRON) CA $0.980B 0.00
ARS Pharmaceuticals (SPRY) US $0.878B 0.00
Organogenesis (ORGO) US $0.830B 0.00
ProKidney (PROK) US $0.795B 0.00
Theravance Biopharma (TBPH) US $0.759B 32.08
Savara (SVRA) US $0.691B 0.00
Esperion Therapeutics (ESPR) US $0.689B 0.00
Elite Pharmaceuticals (ELTP) US $0.680B 0.00
Rigel Pharmaceuticals (RIGL) US $0.627B 5.60
Bioventus (BVS) US $0.619B 12.69
KalVista Pharmaceuticals (KALV) US $0.550B 0.00
Zevra Therapeutics (ZVRA) US $0.512B 0.00
4D Molecular Therapeutics (FDMT) US $0.475B 0.00
Siga Technologies (SIGA) US $0.466B 6.38
Lexeo Therapeutics (LXEO) US $0.460B 0.00
Altimmune (ALT) US $0.445B 0.00
Akebia Therapeutics (AKBA) US $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.411B 9.73
USANA Health Sciences (USNA) US $0.351B 9.79
Nature's Sunshine Products (NATR) US $0.346B 20.60
Lyell Immunopharma (LYEL) US $0.340B 0.00
Galectin Therapeutics (GALT) US $0.335B 0.00
Aldeyra Therapeutics (ALDX) US $0.309B 0.00
Korro Bio (KRRO) US $0.306B 0.00
Pyxis Oncology (PYXS) US $0.297B 0.00
Larimar Therapeutics (LRMR) US $0.294B 0.00
Achieve Life Sciences (ACHV) CA $0.237B 0.00
Journey Medical (DERM) US $0.235B 0.00
Aclaris Therapeutics (ACRS) US $0.231B 0.00
OmniAb (OABI) US $0.214B 0.00
AleAnna (ANNA) US $0.214B 0.00
Heron Therapeutics (HRTX) US $0.204B 0.00
MediWound (MDWD) IL $0.199B 0.00
Profound Medical (PROF) CA $0.181B 0.00
Protara Therapeutics (TARA) US $0.175B 0.00
Innate Pharma SA (IPHYF) FR $0.168B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.148B 0.00
Cassava Sciences (SAVA) US $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.128B 0.00
Incannex Healthcare (IXHL) AU $0.126B 0.00
Avita Medical (RCEL) US $0.121B 0.00
Inhibikase Therapeutics (IKT) US $0.118B 0.00
Context Therapeutics (CNTX) US $0.110B 0.00
Cardiol Therapeutics (CRDL) CA $0.104B 0.00
Surrozen (SRZN) US $0.101B 0.00
Relmada Therapeutics (RLMD) US $0.100B 0.00
Vivani Medical (VANI) US $0.096B 0.00
Champions Oncology (CSBR) US $0.093B 33.90
Karyopharm Therapeutics (KPTI) US $0.093B 0.00
VAXART, INC (VXRT) US $0.091B 0.00
Gain Therapeutics (GANX) US $0.090B 0.00
Unicycive Therapeutics (UNCY) US $0.083B 0.00
Metagenomi (MGX) US $0.081B 0.00
Lite Strategy (LITS) US $0.081B 0.00
Dominari Holdings (DOMH) US $0.080B 0.00
Plus Therapeutics (PSTV) US $0.077B 0.00
Nutriband (NTRB) US $0.072B 0.00
Prelude Therapeutics (PRLD) US $0.071B 0.00
PMV Pharmaceuticals (PMVP) US $0.069B 0.00
Rafael Holdings (RFL) US $0.067B 0.00
Acrivon Therapeutics (ACRV) US $0.064B 0.00
BioNxt Solutions (BNXTF) CA $0.062B 0.00
PolyPid (PYPD) IL $0.059B 0.00
Talphera (TLPH) US $0.059B 0.00
Fractyl Health (GUTS) US $0.056B 0.00
Wellgistics Health (WGRX) US $0.053B 0.00
NRx Pharmaceuticals (NRXP) US $0.050B 0.00
ElectroCore (ECOR) US $0.050B 0.00
Jupiter Neurosciences (JUNS) US $0.048B 0.00
Century Therapeutics (IPSC) US $0.047B 0.00
FibroGen (FGEN) US $0.044B 0.00
Telomir Pharmaceuticals (TELO) US $0.044B 0.00
Tempest Therapeutics (TPST) US $0.043B 0.00
Klotho Neurosciences (KLTO) US $0.039B 0.00
Inotiv (NOTV) US $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.038B 0.00
Verrica Pharmaceuticals (VRCA) US $0.037B 0.00
Mural Oncology (MURA) IE $0.036B 0.00
Liminatus Pharma (LIMN) US $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.030B 24.75
Iterum Therapeutics (ITRM) IE $0.029B 0.00
Cosmos Health (COSM) US $0.025B 0.00
SCYNEXIS (SCYX) US $0.025B 0.00
Enlivex Therapeutics (ENLV) IL $0.024B 0.00
Scienture Holdings (SCNX) US $0.024B 0.00
Mangoceuticals (MGRX) US $0.022B 0.00
Citius Pharmaceuticals (CTXR) US $0.022B 0.00
Vyome Holdings (HIND) US $0.020B 0.00
Heatwurx (PCSA) US $0.020B 0.00
Vivos Therapeutics (VVOS) US $0.019B 0.00
Mannatech (MTEX) US $0.018B 0.00
Natural Alternatives (NAII) US $0.017B 0.00
CASI Pharmaceuticals (CASI) CN $0.016B 0.00
Lipocine (LPCN) US $0.016B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
BioLineRx (BLRX) IL $0.015B 0.00
Traws Pharma (TRAW) US $0.014B 0.02
Ainos (AIMD) US $0.013B 0.00
Ernexa Therapeutics (ERNA) US $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
ProPhase Labs (PRPH) US $0.012B 0.00
VYNE Therapeutics (VYNE) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
Aptorum Group (APM) GB $0.007B 0.00
Biomerica (BMRA) US $0.007B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Nuvilex (PMCB) US $0.006B 0.00
Alaunos Therapeutics (TCRT) US $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.005B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Qualigen Therapeutics (QLGN) US $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Jaguar Animal Health (JAGX) US $0.004B 0.00
CDT Equity (CDT) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.003B 0.00
Indaptus Therapeutics (INDP) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.003B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
SciSparc (SPRC) IL $0.001B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Aditxt (ADTX) US $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.000B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
Indivior (INDV) US $0.000B 15.76
4D Pharma (LBPS) GB $0.000B 0.00
Minerva Neurosciences (NERV) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00